Delivery Order SPE2DB25D7056-SPE2DB25FTMRQ
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dexamethasone 4 mg tablets in unit dose packaging of 100 tablets. This firm fixed-price delivery order, valued at $1,424.94, is scheduled for completion by September 22, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Dexamethasone 4 mg tablets (100 count) with a ceiling value of $1,865.16. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, will be performed at the contractor's Conshohocken facility. The award was made without a set-aside designation,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,488.18 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Dexamethasone 20 mg/5 ml vials. This competitively awarded, firm fixed-price contract is set to be completed by June 30, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- This is a $1,046.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,883,375 units of dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,824.44 on August 13, 2025, to supply Dexamethasone 10mg/ml in vials (25-count units) to the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 10, 2025. The delivery order represents work performed under AmerisourceBergen's larger Indefinite...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMRQDelivery Order
The Defense Logistics Agency awarded a $1,242.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Dexamethasone 4 mg tablets in unit-dose packages of 100 units. This is a non-set-aside competitive award with an ultimate completion date of July 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies across multiple therapeutic domains. The contract supports various federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, as part of DLA's strategic pharmaceutical support initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/30/25 |